Phase Ib/IIa Trial With AC01 in Patients With HFrEF

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

February 23, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

February 1, 2026

Conditions
Heart Failure With Reduced Ejection Fraction
Interventions
DRUG

AC01

AC01 microtablets

Trial Locations (13)

25123

Spedali Civilia di Brescia, Brescia

34149

Azienda Sanitaria Universitaria Integrata, Trieste

413045

Sahlgrenska University Hospital, Gothenburg

1081 HV

Amsterdam University Medical Centre, Amsterdam

9718 GZ

University Medical Centre Groningen/ICON, Groningen

6229 HX

Maastricht Heart and Vascular Center, Maastricht

3015 GD

Erasmus Medical Centre, Rotterdam

222 42

Skånes Universitetssjukhus Lund, Lund

171 76

Karolinska University Hospital, Stockholm

DD1 9SY

Ninewells Hospital and Medical School, Dundee

G12 8QQ

University of Glasgow, Institute of Cardiovascular & Medical Sciences, Glasgow

G81 4DY

Golden Jubilee National Hospital, Glasgow

SE5 9RS

King's College Hospital, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AnaCardio AB

INDUSTRY